These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 18649330)

  • 1. Dissection of the CMV specific T-cell response is required for optimized cardiac transplant monitoring.
    Kirchner A; Hoffmeister B; Cherepnev-G G; Fuhrmann S; Streitz M; Lachmann R; Bunde T; Meij P; Schönemann C; Hetzer R; Lehmkuhl HB; Volkmer-Engert R; Volk HD; Gratama JW; Kern F
    J Med Virol; 2008 Sep; 80(9):1604-14. PubMed ID: 18649330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High levels of CMV-IE-1-specific memory T cells are associated with less alloimmunity and improved renal allograft function.
    Nickel P; Bold G; Presber F; Biti D; Babel N; Kreutzer S; Pratschke J; Schönemann C; Kern F; Volk HD; Reinke P
    Transpl Immunol; 2009 Mar; 20(4):238-42. PubMed ID: 19032982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring cytomegalovirus IE-1 and pp65-specific CD4+ and CD8+ T-cell responses after allogeneic stem cell transplantation may identify patients at risk for recurrent CMV reactivations.
    Gratama JW; Brooimans RA; van der Holt B; Sintnicolaas K; van Doornum G; Niesters HG; Löwenberg B; Cornelissen JJ
    Cytometry B Clin Cytom; 2008 Jul; 74(4):211-20. PubMed ID: 18454493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-cell immunity to subclinical cytomegalovirus infection reduces cardiac allograft disease.
    Tu W; Potena L; Stepick-Biek P; Liu L; Dionis KY; Luikart H; Fearon WF; Holmes TH; Chin C; Cooke JP; Valantine HA; Mocarski ES; Lewis DB
    Circulation; 2006 Oct; 114(15):1608-15. PubMed ID: 17015794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytomegalovirus immune reconstitution occurs in recipients of allogeneic hematopoietic cell transplants irrespective of detectable cytomegalovirus infection.
    Gallez-Hawkins G; Thao L; Lacey SF; Martinez J; Li X; Franck AE; Lomeli NA; Longmate J; Diamond DJ; Spielberger R; Forman SJ; Zaia JA
    Biol Blood Marrow Transplant; 2005 Nov; 11(11):890-902. PubMed ID: 16275592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levels of CMV specific CD4 T cells are dynamic and correlate with CMV viremia after allogeneic stem cell transplantation.
    Widmann T; Sester U; Gärtner BC; Schubert J; Pfreundschuh M; Köhler H; Sester M
    PLoS One; 2008; 3(11):e3634. PubMed ID: 18982061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of cytomegalovirus-specific T-cell reconstitution in patients after various allogeneic haematopoietic stem cell transplantation using interferon-gamma-enzyme-linked immunospot and human leucocyte antigen tetramer assays with an immunodominant T-cell epitope.
    Ohnishi M; Sakurai T; Heike Y; Yamazaki R; Kanda Y; Takaue Y; Mizoguchi H; Kawakami Y
    Br J Haematol; 2005 Nov; 131(4):472-9. PubMed ID: 16281937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective immunity to cytomegalovirus (CMV) retinitis in AIDS is associated with CMV-specific T cells that express interferon- gamma and interleukin-2 and have a CD8+ cell early maturational phenotype.
    Sinclair E; Tan QX; Sharp M; Girling V; Poon C; Natta MV; Jabs DA; Inokuma M; Maecker HT; Bredt B; Jacobson MA;
    J Infect Dis; 2006 Dec; 194(11):1537-46. PubMed ID: 17083038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigen-specific T cell responses induced by Towne cytomegalovirus (CMV) vaccine in CMV-seronegative vaccine recipients.
    Jacobson MA; Sinclair E; Bredt B; Agrillo L; Black D; Epling CL; Carvidi A; Ho T; Bains R; Adler SP
    J Clin Virol; 2006 Mar; 35(3):332-7. PubMed ID: 16387547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viral escape and T-cell immunity during ganciclovir treatment of cytomegalovirus infection: case report of a pancreatico-renal transplant recipient.
    Benz C; Holz G; Michel D; Awerkiew S; Dries V; Stippel D; Goeser T; Busch DH
    Transplantation; 2003 Mar; 75(5):724-7. PubMed ID: 12640316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid generation of CMV pp65-specific T cells for immunotherapy.
    Bao L; Sun Q; Lucas KG
    J Immunother; 2007; 30(5):557-61. PubMed ID: 17589296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytomegalovirus (CMV) IE1- and pp65-specific CD8+ T cell responses broaden over time after primary CMV infection in infants.
    Gibson L; Dooley S; Trzmielina S; Somasundaran M; Fisher D; Revello MG; Luzuriaga K
    J Infect Dis; 2007 Jun; 195(12):1789-98. PubMed ID: 17492595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deficiency of cytomegalovirus (CMV)-specific CD8+ T cells in patients presenting with late-onset CMV disease several years after transplantation.
    Cummins NW; Deziel PJ; Abraham RS; Razonable RR
    Transpl Infect Dis; 2009 Feb; 11(1):20-7. PubMed ID: 18811629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An in vitro model of T cell activation by autologous cytomegalovirus (CMV)-infected human adult endothelial cells: contribution of CMV-enhanced endothelial ICAM-1.
    Waldman WJ; Knight DA; Huang EH
    J Immunol; 1998 Apr; 160(7):3143-51. PubMed ID: 9531269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of cellular immunity to human cytomegalovirus in recipients of allogeneic stem cell transplants.
    Lacey SF; Diamond DJ; Zaia JA
    Biol Blood Marrow Transplant; 2004 Jul; 10(7):433-47. PubMed ID: 15205665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous reconstitution of multiple cytomegalovirus-specific CD8+ cell populations with divergent functionality in hematopoietic stem-cell transplant recipients.
    Lacey SF; Martinez J; Gallez-Hawkins G; Thao L; Longmate J; Haq W; Spielberger R; Forman SJ; Zaia JA; Diamond DJ
    J Infect Dis; 2005 Mar; 191(6):977-84. PubMed ID: 15717275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-helper and T-cytotoxic cell subsets monitoring during active cytomegalovirus infection in liver transplantation.
    Wang YL; Zhang YY; Zhou YL; Zhu ZJ; Tang ZQ; Jiang Y; Peng L; Li G; Zhang XH
    Transplant Proc; 2004 Jun; 36(5):1498-9. PubMed ID: 15251369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD8(+) T-cell immunity to cytomegalovirus.
    Moss P; Khan N
    Hum Immunol; 2004 May; 65(5):456-64. PubMed ID: 15172445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional analysis of cytomegalovirus-specific T lymphocytes compared to tetramer assay in patients undergoing hematopoietic stem cell transplantation.
    Morita-Hoshi Y; Heike Y; Kawakami M; Sugita T; Miura O; Kim SW; Mori SI; Fukuda T; Tanosaki R; Tobinai K; Takaue Y
    Bone Marrow Transplant; 2008 Mar; 41(6):515-21. PubMed ID: 18026143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-helper cell responses in liver transplant recipients: correlation with cytomegalovirus and other major infections.
    Singh N; Gayowski T; Wagener MM; Zeevi A
    Transpl Infect Dis; 2004 Jun; 6(2):93-6. PubMed ID: 15522114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.